Periodic Reporting for period 1 - GIVIREVOL (Host range and genome adaptation of giant viruses)
Periodo di rendicontazione: 2021-04-01 al 2023-03-31
In this project we investigate the host range and genome adaptation of giant viruses by combining in silico and wet-lab strategies. The project is based on the idea that, besides the number of translation-related genes, codon usage is a principal factor in the adaptation of viruses to their hosts, where well-adapted codon usage provides for superior viral fitness. Under this assumption this project has four main objectives: (i) examine whether giant virus codon usage preferences are evolutionary conserved, (ii) assess whether we can computationally predict giant virus host range, (iii) evaluate the in-silico predictions with laboratory experiments, and (iv) investigate the rate of giant virus genome adaptation through experimental evolution.
So far, the results of this project suggest that the number of translation related genes and codon usage preferences alone are not an accurate predictor for giant virus host range nor the rate of genome adaptation. The experimental data that we already have and that we are currently generating will aid us in defining the additional factors that we need to consider to be able to make more accurate predictions. By investigating the evolutionary relationships between giant viruses and their hosts in the context of codon usage preferences, we contribute to a better understanding of the factors determining host range and the evolutionary processes shaping giant virus genomes. Disentangling the connection between genomic content and host range will provide important knowledge in virology, evolutionary biology, genomics, and virus-host interactions.
To better understand the factors that drive the evolution of large viral genomes with a wide range of codon usage preferences, we used experimental evolution. For this we used three different giant viruses and three different hosts. We performed weekly passages of these viruses in their hosts for a total duration of half a year. For Tupanvirus, that has a wide host range, we included additional setups with (i) one host-switch at half of the experiment, (ii) a monthly host switch, (iii) and a weekly host switch. For the three viruses, we observed three different outcomes: (i) a decrease in cytopathic effects (CPE) and viral copy number, (ii) no change in CPE and viral copy number, and (iii) an increase in CPE and viral copy number. Although we have not completely finalized analyzing the genome sequences of the ancestral and evolved viruses, the timing of the increase in the number of mutations correlates well with the observed increase in CPE as well as viral copy number. In line with our initial hypothesis, frequent host switches generate viral variants that are able to perform well in different host species. However, lower viral replication success appears to be an important trade-off for maintaining a mixed viral population that works well in multiple hosts.
To be able to answer our original question on whether codon usage preferences define the rate of genome adaptation of giant viruses, we need to finalize the analysis of the viral genome sequencing along the evolution experiment, and potentially perform additional experiments. Like many other projects, this project was affected by the COVID-19 pandemic. Therefore, we were unfortunately not able disseminate the results at international conferences or at events targeting the general public within the project period. We recently presented our results for the first time at two international conferences: Viruses of Microbes and the IX European Congress of Protistology & Annual Congress of the International Society of Protistologists joint meeting.
A significant number of protists are the causative agents of human disease, including the almost always fatal primary amebic meningoencephalitis, eye infections, malaria, sleeping sickness, and waterborne gastroenteritis. Better understanding protist evolution as well as giant virus host range and genome adaptation will aid us to design studies in which we can use giant viruses as biocontrol agents, where giant viruses can be used to lyse the cells of these pathogenic protists. This can either serve as giant virus therapy to cure protist infected patients or to decrease the chance of infection by aiming to remove pathogenic protists from their natural environment.